Stockscreener 앱 받기
1.05
3.67%
-0.04
시간 외 거래:
1.06
0.01
+0.95%
전일 마감가:
$1.09
열려 있는:
$1.07
하루 거래량:
305.52K
Relative Volume:
1.23
시가총액:
$13.44M
수익:
$43.20M
순이익/손실:
$-11.09M
주가수익비율:
-0.947
EPS:
-1.1088
순현금흐름:
$-9.32M
1주 성능:
+0.00%
1개월 성능:
+8.14%
6개월 성능:
+7.14%
1년 성능:
-0.94%
1일 변동 폭
$1.05
$1.08
1주일 범위
$1.05
$1.09
52주 변동 폭
$0.5547
$1.205
Biofrontera Inc Stock (BFRI) Company Profile
명칭
Biofrontera Inc
전화
781-245-1325
주소
120 PRESIDENTIAL WAY,, WOBURN
Compare BFRI vs TAK, HLN, TEVA, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BFRI
Biofrontera Inc
|
1.05 | 13.96M | 43.20M | -11.09M | -9.32M | -1.1088 |
TAK
Takeda Pharmaceutical Co Adr
|
17.44 | 55.06B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.94 | 43.07B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.08 | 35.88B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
76.92 | 31.59B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
527.94 | 26.32B | 3.17B | 1.29B | 1.01B | 27.09 |
Biofrontera Inc 주식(BFRI)의 최신 뉴스
Biofrontera Inc (BFRI) Cash Flow - TradingKey
Biofrontera Inc (BFRI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Biofrontera Inc (BFRI) Income Statement - TradingKey
Biofrontera Inc (BFRI) Balance Sheet - TradingKey
Biofrontera Inc (BFRI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biofrontera Inc (BFRI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Biofrontera Inc. Revenue Breakdown – BOATS:BFRIW - TradingView
Biofrontera Inc (BFRI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Biofrontera targets cash flow breakeven in 2026 while aiming for 80%-85% gross margin - MSN
Biofrontera Inc. Warrants (BFRIW) Holds Steady at $0.03 – Tight Range Signals Stalemate for Penny-Stock WarrantsFear Greed Index - dars.gov.et
Biofrontera Inc. (BFRI) Q1 2026 Earnings: Wider-than-Expected Loss Signals Heavy Investment PhaseEarnings Power Value - dars.gov.et
Biofrontera Inc. (BFRI) Slides 3.5% as Stock Tests Key Support Near $1.04Liquidity Sweep - dars.gov.et
Enterprise value to EBIT forward of Biofrontera Inc. – NASDAQ:BFRI - TradingView
Frontier tech research, news & data - MLQ.ai
Biofrontera’s Acne PDT Trial Completion: What Investors Should Watch Next - TipRanks
Enterprise value to EBITDA forward of Biofrontera Inc. – NASDAQ:BFRI - TradingView
Biofrontera (BFRI) Q4 2025 earnings summary - Quartr
Biofrontera (BFRI) AGM 2026 Summary - Quartr
Biofrontera (BFRI) Proxy filing Summary - Quartr
Biofrontera’s Phase III Actinic Keratosis Study Nears Data Payoff for Investors - TipRanks
Price to earnings forward of Biofrontera Inc. – NASDAQ:BFRI - TradingView
BFRI SEC FilingsBiofrontera Inc 10-K, 10-Q, 8-K Forms - Stock Titan
BFRIBiofrontera Inc Options - Finviz
Biofrontera Inc. Warrant 2021-27.10.26 on Biofrontera Financial Disclosures & SEC Filings - TradingView
Price to sales forward of Biofrontera Inc. – NASDAQ:BFRI - TradingView
Price to sales forward of Biofrontera, Inc. – MUN:AI10 - TradingView
Price to book forward of Biofrontera Inc. – NASDAQ:BFRI - TradingView
Enterprise value to revenue forward of Biofrontera, Inc. – MUN:AI10 - TradingView
Biofrontera Inc. Warrants (BFRIW) Tumble to $0.02: A 29% DeclineMutual Fund Flow - dars.gov.et
A3EFRZ Forecast — Price Target — Prediction for 2027 - TradingView
AI10 Forecast — Price Target — Prediction for 2027 - TradingView
Biofrontera, Inc. Actuals & Estimates (NASDAQ:BFRI) - TradingView
Biofrontera Inc (BFRI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BFRI Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of Biofrontera Inc. – NASDAQ:BFRIW - TradingView
Price to sales forward of Biofrontera Inc. – NASDAQ:BFRIW - TradingView
Biofrontera Inc (BFRI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Biofrontera Inc (BFRI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BFRI Q1 2026 Earnings: Significant EPS Miss Amid Operational ChallengesEarnings Yield Analysis - dars.gov.et
Biofrontera Inc. (BFRI) Shows Modest Bounce Near Key Support LevelEntry Point Alerts - DonanımHaber
Biofrontera Inc.'s (NASDAQ:BFRI) Path To Profitability - simplywall.st
Biofrontera Inc (BFRI) Institutional Confidence - TradingKey
Biofrontera Inc (BFRI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Biofrontera Inc (BFRIW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biofrontera Shareholders Approve Director Elections and Equity Plan - TipRanks
Biofrontera (NASDAQ: BFRI) OKs directors, bigger incentive plan and auditor - Stock Titan
Biofrontera Inc (BFRIW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Biofrontera Inc (BFRIW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Biofrontera Inc (BFRIW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Biofrontera Inc (BFRIW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Biofrontera Inc (BFRIW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Biofrontera Inc (BFRI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.30%
2.01%
자본화:
|
볼륨(24시간):